ABL SH3 mutant inhibits BCR-ABL activity and increases imatinib sensitivity by targeting RIN1 protein in CML cell
Author:
Funder
National Science Foundation of China
Chongqing Medical University
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference27 articles.
1. Regulation of the c-Abl and Bcr-Abl tyrosine kinases;Hantschel;Nat. Rev. Mol. Cell Biol,2004
2. BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib;Sherbenou;Blood,2010
3. Structural basis for the autoinhibition of c-Abl tyrosine kinase;Nagar;Cell,2003
4. Structure and dynamic regulation of Abl kinases;Panjarian;J. Biol. Chem,2013
5. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase;Nagar;Mol. Cell,2006
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-Term Molecular Remission after Treatment with Imatinib in a Chronic Myeloid Leukemia Patient with Extreme Thrombocytosis Harboring Rare e14a3 (b3a3) BCR::ABL1 Transcript: A Case Report;Current Oncology;2022-10-28
2. Sulfasalazine synergistically enhances the inhibitory effects of imatinib against hepatocellular carcinoma (HCC) cells by targeting NFκB, BCR/ABL, and PI3K/AKT signaling pathway‐related proteins;FEBS Open Bio;2021-02-20
3. RIN 1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25;Cancer Science;2017-07-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3